Chemical inhibitors of HATH-1 target various signaling pathways to achieve functional inhibition of this protein, which plays a role in neuronal differentiation and development. Cyclopamine and Jervine, for instance, exert their inhibitory effects by directly antagonizing the Hedgehog signaling pathway. This pathway is integral for the proliferation and differentiation of neuronal precursors, and its disruption results in the downregulation of transcription factors and genes that are regulated by HATH-1, leading to its inhibition. Similarly, GANT61 disrupts the Hedgehog pathway but does so by directly inhibiting GLI transcription factors. This prevents the transcription of target genes that would be activated by HATH-1, thereby inhibiting its function.
Further targeting the Hedgehog pathway are chemicals like LY2940680, Vismodegib, Saridegib, Sonidegib, Glasdegib, and PF-5274857, all of which bind to and inhibit Smoothened (SMO). This inhibition is crucial as SMO is a pivotal component of the Hedgehog signaling cascade; when its function is inhibited, the downstream signaling necessary for HATH-1's role in neurogenesis is suppressed. Itraconazole, while primarily an antifungal agent, also antagonizes Hedgehog signaling, thus contributing to the functional inhibition of HATH-1 by disrupting the transcriptional programs within its purview. LDE225, which is another name for Sonidegib, reiterates this mechanism of Smoothened inhibition, reinforcing the blockade of HATH-1's downstream activities. Lastly, TWS119 approaches the inhibition of HATH-1 from a different angle by targeting glycogen synthase kinase-3β (GSK-3β). Inhibition of GSK-3β alters Wnt signaling, which is another pathway that influences transcriptional activities and cellular processes that HATH-1 would normally regulate, resulting in the inhibition of its functional activity. These chemical inhibitors collectively demonstrate a robust strategy to diminish the functional capabilities of HATH-1 through the concerted blockade of critical signaling pathways it is associated with.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $92.00 $204.00 | 19 | |
Cyclopamine inhibits the Hedgehog signaling pathway, which is critical for the proliferation and differentiation of neuronal precursors. Inhibition of this pathway can lead to reduced activity of related transcription factors, which may include HATH-1, leading to functional inhibition. | ||||||
GANT61 | 500579-04-4 | sc-202630 sc-202630A sc-202630B | 1 mg 5 mg 10 mg | $63.00 $128.00 $200.00 | 6 | |
GANT61 directly inhibits GLI transcription factors within the Hedgehog pathway, which are upstream of neuronal differentiation processes involving HATH-1, resulting in its functional inhibition by preventing the transcription of target genes. | ||||||
Jervine | 469-59-0 | sc-200934 sc-200934A | 1 mg 5 mg | $66.00 $240.00 | 1 | |
Jervine functions similarly to cyclopamine by inhibiting the Hedgehog signaling pathway. As HATH-1 is involved in neuronal development, the inhibition of this pathway can result in the functional inhibition of HATH-1 by limiting the transcriptional activation of its downstream targets. | ||||||
Vismodegib | 879085-55-9 | sc-396759 sc-396759A | 10 mg 25 mg | $80.00 $96.00 | 1 | |
Vismodegib binds to and inhibits Smoothened, a critical molecule in the Hedgehog signaling pathway, which can lead to the downregulation of transcription factors and genes that are potentially regulated by HATH-1. | ||||||
Saridegib | 1037210-93-7 | sc-507351 | 5 mg | $3500.00 | ||
Saridegib inhibits Smoothened in the Hedgehog pathway. This blockade can prevent the activation of downstream effectors that may be necessary for HATH-1's function in neuronal differentiation. | ||||||
Erismodegib | 956697-53-3 | sc-396280 sc-396280A | 10 mg 100 mg | $255.00 $918.00 | ||
Sonidegib is an antagonist of Smoothened, which is part of the Hedgehog signaling pathway. Its inhibition can decrease the activity of downstream elements in the pathway that may be necessary for HATH-1 activity. | ||||||
Itraconazole | 84625-61-6 | sc-205724 sc-205724A | 50 mg 100 mg | $76.00 $139.00 | 23 | |
Itraconazole has been found to antagonize Hedgehog signaling. By inhibiting this pathway, it can indirectly lead to the functional inhibition of HATH-1 by disrupting the transcriptional programs it may regulate. | ||||||
Glasdegib | 1095173-27-5 | sc-507353 | 5 mg | $165.00 | ||
Glasdegib inhibits Smoothened in the Hedgehog pathway, potentially reducing the transcriptional activity of downstream targets that are involved in the functional role of HATH-1. | ||||||
PF-5274857 | 1373615-35-0 | sc-478208 | 5 mg | $360.00 | ||
PF-5274857 is a specific inhibitor of Smoothened, which when inhibited, may decrease downstream signaling required for HATH-1 function in the neuronal differentiation process. | ||||||